Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cardiometabolic risk reduction after metabolic surgery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Time-perspective in cardiovascular risk of NSAID use after first-time myocardial infarction

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Exploration of pathophysiological pathways for incident atrial fibrillation using a multiplex proteomic chip

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Hutchinson's sign of ophthalmic zoster

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Making sense of subclinical cardiac alterations in patients with diabetes

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  4. Caffeine and myocardial perfusion: a clinical perspective

    Publikation: Bidrag til tidsskriftLederForskningpeer review

  5. Conservatively managed saddle pulmonary embolism

    Publikation: Bidrag til tidsskriftKommentar/debatForskningpeer review

Vis graf over relationer

PURPOSE OF REVIEW: Metabolic surgery provides the largest and most durable weight loss in persons with obesity. There is abundant randomized evidence to show its superiority over medical treatment alone in achieving improved glycemic control.

RECENT FINDINGS: Recent trials have also demonstrated a significant reduction in cardiovascular risk factor burden, whereas data from observational studies suggest an ability to reduce overt cardiovascular events and mortality.

SUMMARY: In this review, we briefly describe the surgical procedures involved and their indications. We further provide a summary of the effects of metabolic surgery on weight loss, glycemic control, and clinical outcomes.

OriginalsprogEngelsk
TidsskriftCurrent Opinion in Cardiology
Vol/bind34
Udgave nummer6
Sider (fra-til)663-672
ISSN0268-4705
DOI
StatusUdgivet - 2019

ID: 58155101